Originally published on Technavio: Vaccine Research Market Analysis - Forecast and Analysis 2023-2027
Vaccine Research Market Forecast 2023-2027:

The global vaccine research market size is projected to expand by USD 17.59 billion, growing at a CAGR of 9.88% from 2022 to 2027.

An essential driver of global market growth is the ongoing research for novel adjuvants and vaccine delivery technologies aimed at enhancing vaccine efficacy and stability. Adjuvants, chemicals injected into vaccines to improve immune system responses, are under investigation for improved immune response mechanisms, ultimately boosting vaccine efficacy. Researchers strive to refine vaccine formulations, augment their efficacy, and potentially reduce the number of required doses. These advancements address the global demand for effective vaccinations against various infectious diseases, contributing to the production of more potent vaccines.

Market Forecast
The public segment is expected to significantly contribute to market growth during the forecast period. Government organizations, such as the US National Institute of Allergy and Infectious Diseases (NIAID) and the US National Institutes of Health (NIH), fall under this segment. Governments worldwide have invested extensively in vaccine research, particularly evident in the development and deployment of various COVID-19 vaccines. Massive and sustained investments over decades have led to significant advancements.

Private 
Private pharmaceutical companies have been pioneers in discovering, developing, and delivering effective vaccines for over a century. Vendors employ various vaccine R&D strategies, collaborating with governments, academics, and NGOs globally. The COVID-19 pandemic has stimulated private R&D spending, with government support further accelerating vaccine development efforts.

Age Group Analysis

Pediatric  
The pediatric age group holds immense significance in the global market, given the sustained focus on creating and delivering vaccines for children. Global vaccination programs have significantly improved children's health, eradicating infectious childhood diseases. Rising R&D spending, stringent regulatory standards, and increasing demand for safe and efficacious vaccines for children characterize the market environment. Ongoing developments include new vaccines to prevent diseases like rotavirus and pneumococcal infections, contributing to market growth.

Adult  
Similar to the pediatric age group, the adult segment remains crucial due to sustained efforts in vaccine creation and delivery. Global childhood vaccination programs have drastically improved children's health, leading to the eradication of diseases like measles. The emphasis on pediatric vaccinations underscores the commitment to preserving children's health, driving market growth during the forecast period.

Regional Analysis

North America is anticipated to contribute 41% to global market growth during the forecast period. Analysts attribute this to the prevalence of infectious diseases like influenza, hepatitis A, hepatitis B, HIV, measles, malaria, and tuberculosis, along with the rise in non-infectious diseases such as cancer. Developed countries in the region experience a steady increase in infectious and non-infectious diseases. Government collaboration with private entities aims to advance R&D efforts against infectious diseases.

Key Vaccine Research Market Players 
Companies employ various strategies, including strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their market presence. The report includes detailed analyses of the competitive landscape, featuring information about 20 market companies, including:

- Abbott Laboratories - Offers vaccine research for therapy areas such as Anti incentives, Cardio Diabeto, and Neuro Psychiat.
Qualitative and quantitative analyses of vendors help clients understand the broader business environment, including strengths and weaknesses of key market players. Data is analyzed to categorize vendors based on factors like being pure play, category-focused, industry-focused, and diversified; and to categorize them as dominant, leading, strong, tentative, and weak.

Market: Key Trends, Challenges, and Customer Landscape  
The report analyzes factors influencing market growth, utilizing 2022 as the base year. Key trends and challenges are highlighted.

Significant Trends
The primary trend driving market growth is the adoption of AI to expedite vaccine R&D. Artificial intelligence aids in discovering and developing new vaccines by converting data into valuable knowledge. AI tools assist vaccine researchers in gaining new biological insights, speeding up the design and development of vaccines. Real-time image analysis helps identify genetic mutations and variations, aiding in the identification of viruses with new variants and mutations. AI plays a pivotal role in vaccine development and is expected to be a significant trend driving market growth.

Major Challenges  
The high cost of vaccine research, development, and manufacturing poses a significant challenge in the market. Despite achievements in combating life-threatening diseases, the need for new vaccines persists. Slow progress is attributed to substantial investments required for vaccine development and manufacture. Initiatives like the Consortium for Epidemiological Preparedness Innovations (CEPI) aim to address these challenges by pooling resources for the development of vaccines to combat epidemics and pandemics.

Key Market Customer Landscape 
The market forecasting report includes the adoption lifecycle, covering stages from innovator to laggard. It focuses on adoption rates in different regions based on penetration. The report also incorporates key purchase criteria and drivers of price sensitivity to assist companies in evaluating and developing growth strategies.

To Learn deeper into this report , View Sample PDF 
The Global Vaccine Research Market exhibits promising growth with a Compound Annual Growth Rate (CAGR). The research study analyzes industry trends, pricing, and patents. Key stakeholders and buying behavior are engaged through conference and webinar materials. Targeted diseases include dengue fever, Zika virus, Chikungunya, and TB, with oversight from WHO and the European Centre for Disease Prevention and Control. Regulatory bodies such as the US FDA and ICH monitor development costs. Vaccine types encompass conjugate, recombinant, inactivated & subunit, live attenuated, and tox.

For more information please contact.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/